The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01384136|
Recruitment Status : Unknown
Verified June 2011 by Meir Medical Center.
Recruitment status was: Active, not recruiting
First Posted : June 28, 2011
Last Update Posted : June 28, 2011
The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress.
The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes.
The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.
|Condition or disease|
|Telomere Length Mechanisms of Telomter Homeostasis High Risk Pregnancies|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies|
|Study Start Date :||June 2011|
|Estimated Primary Completion Date :||June 2015|
|Estimated Study Completion Date :||June 2015|
|High risk pregnancy|
||Control - Normal low risk pregnancies|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01384136
|Meir Medical Center|
|Kfar Saba, Israel|